Find comprehensive information on Benign Prostatic Hyperplasia (BPH) and Prostate Gland Enlargement diagnosis, including ICD-10 codes (N40), clinical documentation improvement (CDI) best practices, medical coding guidelines, and healthcare provider resources. Learn about symptoms, treatment options, and differential diagnosis for prostate hypertrophy. Explore relevant medical terminology, clinical findings, and coding tips for accurate documentation and reimbursement. Improve your understanding of enlarged prostate, prostatism, and lower urinary tract symptoms (LUTS) related to BPH.
Also known as
Diseases of male genital organs
Covers various male reproductive system disorders, including prostate conditions.
General symptoms and signs urinary system
Includes symptoms related to urinary issues, often associated with prostate enlargement.
Heart failure
While not directly related, heart failure can be a complication of certain prostate treatments.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the prostatic hypertrophy benign?
When to use each related code
| Description |
|---|
| Prostate enlargement, non-cancerous |
| Prostate cancer |
| Prostatitis, inflamed prostate |
Using unspecified codes (e.g., N40.9) when clinical documentation supports a more specific BPH diagnosis (e.g., N40.0, N40.1) leads to underpayment and inaccurate data.
Lack of proper clinical indicators in documentation to support the diagnosis of prostate hypertrophy, impacting coding accuracy and reimbursement.
Insufficient documentation of co-existing conditions (e.g., urinary retention, bladder outlet obstruction) with BPH can impact severity and reimbursement.
Patient presents with symptoms suggestive of benign prostatic hyperplasia (BPH), also known as enlarged prostate. The patient reports lower urinary tract symptoms (LUTS) including weak urinary stream, hesitancy, straining to void, post-void dribbling, nocturia, urinary urgency, and a sensation of incomplete emptying. Digital rectal exam (DRE) revealed an enlarged, smooth, and firm prostate without nodules or tenderness. The prostate volume was estimated to be approximately [insert estimated prostate volume] cc. Patient denies hematuria, dysuria, or fever. No history of prostate cancer. Differential diagnosis includes benign prostatic obstruction, bladder outlet obstruction, urinary tract infection, and prostate cancer. Urinalysis and prostate-specific antigen (PSA) testing ordered to rule out infection and malignancy. Based on clinical findings and patient history, the preliminary diagnosis is benign prostatic hypertrophy. Treatment plan will be discussed with the patient after review of laboratory results and may include watchful waiting, lifestyle modifications, alpha-blockers, 5-alpha reductase inhibitors, or minimally invasive procedures such as transurethral resection of the prostate (TURP). Patient education provided on prostate health, BPH management, and the importance of follow-up appointments. ICD-10 code N40.1, benign prostatic hyperplasia, is assigned. CPT codes for evaluation and management services will be determined based on the complexity of the visit.